Cas:61123-13-5 [Pyr6]-Substance P (6-11) manufacturer & supplier

Chemical Name:[Pyr6]-Substance P (6-11)

CAS.NO:61123-13-5

Synonyms:[PYR1]-SUBSTANCE P (6-11);Substance P,fragment 6-11,[pGlu6];pGln-Phe-Phe-Gly-Leu-Met-NH2;PGLU-PHE-PHE-GLY-LEU-MET-NH2;substance P (6-11),pGlu(6);(PYR6)-SUBSTANCE P (6-11);SUBSTANCE P [PGLU6]-FRAGMENT 6-11;PYR-PHE-PHE-GLY-LEU-MET-NH2;GLP-PHE-PHE-GLY-LEU-MET-NH2;pyroglutamyl-phenylalanyl-phenylalanine-glycyl-leucyl-methionine amide;[GLP6] SUBSTANCE P (6-11);(p-Glu6)SP6-11;pglu6-substance P fragment 6-11;[pGlu(6)]-substance P(6-11)

Molecular Formula:C₃₆H₄₉N₇O₇S

Molecular Weight:723.88200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:1195.9ºC at 760 mmHg

Density:1.247g/cm3

Index of Refraction:1.579

PSA:242.99000

Exact Mass:723.34100

LogP:3.07390

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like [PYR1]-SUBSTANCE P (6-11) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[pGlu(6)]-substance P(6-11) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,pglu6-substance P fragment 6-11 Use and application,pGln-Phe-Phe-Gly-Leu-Met-NH2 technical grade,usp/ep/jp grade.

Related News: Soliris would need a “substantial discount” to reach a more appropriate price, according to its report. Using the widely leveraged measure for disease burden known as quality-adjusted life year (QALY), ICER calculated a range of $6,900 to achieve $50,000 per QALY to $25,700 to hit $200,000 per QALY. 2-Morpholino benzene diazonium ion manufacturers Earlier this month, the drugmaker lifted a voluntary EU marketing hold on Zynteglo for beta thalassemia, after a patient death in one of the drugmaker’s other products, LentiGlobin, halted clinical studies. 2,4(1H,3H)-Pyrimidinedione, 1-(2-hydroxycyclohexyl)- suppliers It’s official. Nearly two years after the FDA granted conditional approval to Merck’s Keytruda and Eisai’s Lenvima for endometrial cancer, the U.S. regulator has blessed the combination therapy, with no strings attached. 1-((2-chlorophenyl)(4-chlorophenyl)methyl)piperazine vendor & factory.